Adjuvant therapy of triple negative breast cancer
- 22 January 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 120 (2), 285-291
- https://doi.org/10.1007/s10549-010-0736-z
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast CancerJournal of Clinical Oncology, 2009
- Fragile histidine triad protein, WW domain-containing oxidoreductase protein Wwox, and activator protein 2γ expression levels correlate with basal phenotype in breast cancerCancer, 2009
- RNA-Seq: a revolutionary tool for transcriptomicsNature Reviews Genetics, 2009
- Sites of distant recurrence and clinical outcomes in patients with metastatic triple‐negative breast cancerCancer, 2008
- Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotypeBritish Journal of Cancer, 2008
- Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repairNature Genetics, 2007
- Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patientsBreast Cancer Research and Treatment, 2007
- The resurgence of platinum-based cancer chemotherapyNature Reviews Cancer, 2007
- Prognostic markers in triple‐negative breast cancerCancer, 2006
- Hallmarks of 'BRCAness' in sporadic cancersNature Reviews Cancer, 2004